Trump Spends First Half Of Second Term Dismantling The Nation's Public Health System, Resolving Long-Standing Concern That The Federal Government Was Still Trying To Keep Americans From Getting Sick

The Filing

WASHINGTON. The Trump administration confirmed this week that 15 months of sustained federal action against the nation's public health apparatus had achieved its central aim, ensuring that the United States government is no longer meaningfully organized around the goal of preventing Americans from becoming sick.

The work began on the first day of the term, when the President withdrew the country from the World Health Organization, and accelerated in February with the confirmation of Robert F. Kennedy Jr. as Secretary of Health and Human Services. In the months that followed, the department fired the entire 17-member federal vaccine advisory committee in a single afternoon, replaced it with members more skeptical of vaccines, ended the recommendation that healthy children and pregnant women receive the COVID vaccine, and canceled roughly $500 million in research on the mRNA platform recently credited with saving millions of lives. Officials described the changes as the restoration of public trust rather than the dismantling of the system that had earned it.

"For too long the federal government has been telling Americans which shots to get, which outbreaks to worry about, and which science to believe," said a senior administration official, who noted that roughly 20,000 jobs had been eliminated across HHS, the CDC, the FDA, and the NIH. "We are returning those decisions to the American people, most of whom we expect will make them alone, at home, after watching a video."

To ensure the changes could not be easily reversed, the administration froze NIH grants and capped indirect research costs, delaying studies on cancer and Alzheimer's; halted CDC programs that track the spread of infectious disease; and signed into law the largest Medicaid cut in American history, which the Congressional Budget Office estimated would leave 10 to 17 million additional Americans without health coverage. Officials explained that eliminating both the disease programs and the people who measure disease represented sound management, since an outbreak that is no longer counted cannot produce alarming numbers.

The approach was tested in real time. A measles outbreak that began in Texas produced the first American measles deaths in a decade as the Secretary publicly questioned the vaccine, and by early 2026 the administration's response to the spread of H5N1 bird flu was widely faulted as inadequate by the remaining health officials qualified to assess it. Department representatives stressed that Americans would continue to encounter viruses, bacteria, and chronic illness on the usual schedule, now without the federal government attempting to intervene.

At press time, the administration confirmed that it considered the threat of federal public health policy to be fully contained, citing the steadily shrinking number of scientists, programs, and insured citizens left to protect.

Who Benefits

§Donald J. Trump, who campaigned alongside the "medical freedom" movement and can present the rollback of federal public-health authority as a promise kept.
§Robert F. Kennedy Jr., whose decades of vaccine skepticism became the official posture of the department he now runs.
§HHS leadership, including NIH Director Jay Bhattacharya and FDA Commissioner Marty Makary, elevated to lead the institutions they had spent years criticizing.
§The anti-vaccine advocacy movement and adjacent online media, whose long-marginalized positions are now federal recommendations.
§Wellness influencers and the dietary-supplement industry, positioned as the preferred alternative to the public-health guidance being abandoned.
§Private health insurers, relieved of the cost of millions of Americans dropped from Medicaid.
§The pharmaceutical defense bar, now facing a regulator with diminished capacity to scrutinize it.
§The raw-milk sector and large industrial dairy and poultry operations, an H5N1 vector facing minimal new biosecurity rules.
§Foreign biomedical sectors in China and the European Union, which gain ground as U.S. research funding and scientific talent recede.
§The People's Republic of China and other rivals, which benefit incrementally whenever the United States weakens the health of its own working-age population.
§Future infectious diseases, granted an operating environment with fewer monitors, fewer vaccines, and fewer rules.

Sourced to the public record · presented without editorial embellishment